Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126472881 | 12647288 | 1 | I | 20160801 | 20160812 | 20160812 | EXP | IT-MLMSERVICE-20160801-0378150-1 | ES-LUPIN PHARMACEUTICALS INC.-2016-03547 | LUPIN | GARCIA- ALGAR O, MARCHEI E, PALMI I, PICHINI S, PACIFICI R, AIRALDI I, ORVAY J, SERRA J, SERRA B. SEGMENTAL HAIR TESTING TO DISCLOSE CHRONIC EXPOSURE TO PSYCHOACTIVE DRUGS. ADICCIONES. 2016;28(3):158-162. | 4.00 | YR | M | Y | 0.00000 | 20160812 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126472881 | 12647288 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNKNOWN | 77670 | ||||||||||
| 126472881 | 12647288 | 2 | SS | QUETIAPINE. | QUETIAPINE | 1 | Unknown | UNKNOWN | 201109 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126472881 | 12647288 | 1 | Product used for unknown indication |
| 126472881 | 12647288 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126472881 | 12647288 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126472881 | 12647288 | Asthenia | |
| 126472881 | 12647288 | Blepharospasm | |
| 126472881 | 12647288 | Constipation | |
| 126472881 | 12647288 | Dysarthria | |
| 126472881 | 12647288 | Dystonia | |
| 126472881 | 12647288 | Extrapyramidal disorder | |
| 126472881 | 12647288 | Lacrimation increased | |
| 126472881 | 12647288 | Miosis | |
| 126472881 | 12647288 | Mydriasis | |
| 126472881 | 12647288 | Rash erythematous | |
| 126472881 | 12647288 | Somnolence | |
| 126472881 | 12647288 | Tonic convulsion | |
| 126472881 | 12647288 | Toxicity to various agents | |
| 126472881 | 12647288 | Urinary incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |